[Therapy with trimethoprim-sulfamethoxazole].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002006:Brucellosis / Q000188:drug therapy; D004755:Enterobacteriaceae / Q000187:drug effects; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006069:Gonorrhea / Q000188:drug therapy; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D008581:Meningitis / Q000188:drug therapy; D009344:Neisseria gonorrhoeae / Q000187:drug effects; D010019:Osteomyelitis / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Behandlung mit Trimethoprim-Sulfamethoxazol.